Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
14.25
Dollar change
-0.85
Percentage change
-5.63
%
Index- P/E- EPS (ttm)-0.77 Insider Own1.07% Shs Outstand9.49M Perf Week-10.66%
Market Cap135.23M Forward P/E- EPS next Y-1.86 Insider Trans0.00% Shs Float9.39M Perf Month-0.84%
Income-6.72M PEG- EPS next Q-0.41 Inst Own26.60% Short Float1.63% Perf Quarter38.48%
Sales18.69M P/S7.24 EPS this Y-157.33% Inst Trans- Short Ratio2.49 Perf Half Y54.89%
Book/sh3.43 P/B4.16 EPS next Y3.63% ROA-11.53% Short Interest0.15M Perf Year12.38%
Cash/sh4.40 P/C3.24 EPS next 5Y- ROE-31.60% 52W Range7.10 - 17.25 Perf YTD40.12%
Dividend Est.- P/FCF- EPS past 5Y-22.25% ROI-17.70% 52W High-17.39% Beta0.94
Dividend TTM- Quick Ratio4.33 Sales past 5Y158.87% Gross Margin19.15% 52W Low100.70% ATR (14)0.84
Dividend Ex-Date- Current Ratio4.59 EPS Y/Y TTM80.05% Oper. Margin-82.96% RSI (14)42.19 Volatility6.71% 5.97%
Employees100 Debt/Eq0.21 Sales Y/Y TTM-29.48% Profit Margin-35.94% Recom1.00 Target Price28.50
Option/ShortYes / Yes LT Debt/Eq0.20 EPS Q/Q83.95% Payout- Rel Volume2.85 Prev Close15.10
Sales Surprise0.17% EPS Surprise27.62% Sales Q/Q-54.05% EarningsMar 21 BMO Avg Volume61.53K Price14.25
SMA20-8.97% SMA501.84% SMA20035.22% Trades Volume175,162 Change-5.63%
Date Action Analyst Rating Change Price Target Change
Dec-22-22Initiated Maxim Group Buy $11
Jul-18-22Resumed Oppenheimer Outperform $7
Sep-23-20Initiated BTIG Research Buy $6
Nov-28-16Initiated Aegis Capital Buy $11
Aug-17-16Initiated Wells Fargo Outperform
Apr-16-14Initiated Oppenheimer Outperform $25
Mar-25-24 09:55AM
08:50AM
Mar-21-24 11:54AM
08:25AM
07:25AM
07:00AM Loading…
07:00AM
Mar-14-24 08:00AM
Mar-06-24 08:46AM
Feb-12-24 07:00AM
Feb-05-24 08:00AM
Jan-15-24 09:55AM
Jan-09-24 06:21PM
08:48AM
07:00AM
Dec-28-23 07:00AM
08:00AM Loading…
Dec-21-23 08:00AM
Dec-13-23 09:55AM
Nov-27-23 09:55AM
Nov-21-23 07:12AM
07:02AM
07:00AM
Nov-14-23 08:02AM
Nov-13-23 07:00AM
Nov-08-23 07:00AM
Oct-11-23 06:00AM
Oct-09-23 07:34AM
Oct-03-23 01:20PM
Sep-29-23 08:00AM
Sep-26-23 07:00AM
Sep-21-23 06:00AM
08:00AM Loading…
Sep-11-23 08:00AM
Sep-05-23 08:00AM
Aug-15-23 05:15PM
04:11PM
04:03PM
04:02PM
04:01PM
Aug-07-23 08:00AM
Aug-01-23 07:30AM
Jul-11-23 06:05AM
Jul-10-23 07:30AM
Jul-03-23 07:00AM
Jun-28-23 06:51AM
Jun-14-23 08:00AM
Jun-01-23 06:07AM
May-30-23 08:15AM
07:08AM
07:00AM
May-12-23 08:00AM
May-09-23 07:30AM
Apr-26-23 08:00AM
Apr-19-23 11:40AM
Mar-18-23 08:26AM
08:22AM
Mar-16-23 08:35AM
07:10AM
07:00AM
Mar-09-23 10:00AM
Mar-06-23 07:00AM
Mar-02-23 08:47AM
Feb-23-23 08:00AM
Feb-16-23 05:31AM
Feb-07-23 04:01PM
Feb-03-23 10:30AM
Jan-13-23 10:19AM
Jan-06-23 07:19AM
Dec-30-22 05:26AM
Dec-29-22 01:46PM
Dec-23-22 08:00AM
Dec-20-22 08:00AM
Dec-19-22 07:00AM
Dec-13-22 05:30AM
Dec-05-22 04:05PM
Nov-15-22 08:15AM
07:00AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-25-22 07:00AM
Oct-18-22 07:00AM
Oct-07-22 06:00AM
Sep-22-22 08:02AM
Sep-20-22 07:00AM
Sep-12-22 08:00AM
Aug-23-22 07:00AM
Aug-15-22 06:08AM
Aug-09-22 08:45AM
07:30AM
Aug-08-22 04:05PM
Aug-03-22 07:30AM
Aug-02-22 10:00AM
Aug-01-22 08:00AM
Jul-11-22 11:12AM
07:00AM
Jul-08-22 08:00AM
Jul-07-22 09:19AM
07:00AM
Jul-05-22 04:05PM
Jul-04-22 03:01PM
Jun-30-22 07:00AM
May-19-22 07:24AM
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.